Just had a quick look at the AGM presentation, and the way I read it, the Australian results is what they will be using for the end of Phase 2 meeting as USA results were skewed. (Just my opinion)
As per AGM Presentation page 8
"Patients in the USA that received vehicle had an unusually high vehicle response which skewed the overall primary endpoint"
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-649
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.232M | 3.263M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 413183 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |